Accurate, balanced evidence-based information about medicines
Email this page
Print
Bookmark and share
Bigger
SmallerRosiglitazone (Avandia) and rosiglitazone with metformin (Avandamet) for type 2 diabetes mellitus --- New York Heart Association grading of heart failure (NYHA) Rosiglitazone (Avandia) and rosiglitazone with metformin (Avandamet) for type 2 diabetes mellitus --- New York Heart Association grading of heart failure (NYHA)
Published 2008-12-01 00:00:00
This page contains additional content about the article Rosiglitazone (Avandia) and rosiglitazone with metformin (Avandamet) for type 2 diabetes mellitus, first published in NPS RADAR in April 2004, and last updated in December 2008.
Class I
No limitations. Ordinary physical activity does not cause undue fatigue, dyspnoea or palpitations (asymptomatic left ventricular dysfunction).
Class II
Slight limitation of physical activity. Ordinary physical activity results in fatigue, palpitation, dyspnoea or angina pectoris (mild chronic heart failure).
Class III
Marked limitation of physical activity. Less than ordinary physical activity leads to symptoms (moderate chronic heart failure).
Class IV
Unable to carry on any physical activity without discomfort. Symptoms of chronic heart failure present at rest (severe chronic heart failure).
Published 2008-12-01 00:00:00
The information contained in this material is derived from a critical analysis of a wide range of authoritative evidence. Any treatment decisions based on this information should be made in the context of the clinical circumstances of each patient.
RSS feed
